Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Agenda
Membership
Join Today
Event Agenda
Video
Careers
Home
Tags
TNBC
Tag: TNBC
ESMO 2020: Encouraging Early-Stage Clinical Results with Sacituzumab Govitecan in Brain...
Editorial Team
-
September 18, 2020
Risk of Recurrence of Triple-Negative Breast Cancer May be Predicted by...
Peter Hofland, Ph.D
-
April 24, 2020
Sacituzumab Govitecan Approved in Metastatic Triple-negative Breast Cancer
Peter Hofland, Ph.D
-
April 22, 2020
Radiation, Inflammation and Triple-Negative Breast Cancer: A Study
Peter Hofland, Ph.D
-
February 24, 2020
SABCS 2019: Circulating Tumor DNA may be a Predictor of Recurrence...
Peter Hofland, Ph.D
-
December 14, 2019
ESMO 2019: Sacituzumab Govitecan in Metastatic Urothelial Cancer and Breast Cancer
Peter Hofland, Ph.D
-
September 30, 2019
Understanding Disparities in TNBC may Help to Better Inform Practice and...
Peter Hofland, Ph.D
-
July 10, 2019
First Patient Enrolled in Non-Pharmaceutical Multi-Center, Triple-Negative Breast Cancer Clinical Trial
Peter Hofland, Ph.D
-
June 10, 2019
Stopping Triple-negative Breast Cancer in its Tracks
Salman M. Hyder, PhD
-
May 24, 2019
No Significant Improvement in Early-stage TNBC Patients Treated with Adjuvant Capecitabine
Peter Hofland, Ph.D
-
December 7, 2018
1
2
3
Page 2 of 3
LATEST NEWS
The Impact of the Failure: HSBC’s Acquisition of SVB UK may offer New Opportunities...
Editorial Team
-
March 31, 2023
UK Cancer Patients to Receive the First Immunotherapy for Advanced Cervical Cancer
Editorial Team
-
March 30, 2023
Exai Bio and Quantum Leap Healthcare Collaborative Announce Expanded Participation in I-SPY 2 Trial
Editorial Team
-
March 30, 2023
Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past
Julie Appleby
-
March 30, 2023
Oral Developability Assessment and Manufacturing Solution may Advance Targeted Protein Degraders
Editorial Team
-
March 29, 2023
X